VENTRIX
Myocardial Infarction; Heart Failure; Left Ventricular Remodeling
Kelly Wilson | Kelly.Wilson@allina.com | 612-863-6288
Evaluate the safety and feasibility of investigational VentriGel delivered via endomyocardial injections using NOGA mapping/Myostar catheter to subjects with left ventricular ejection fraction (LVEF) 25 to 45% secondary to MI. Secondary endpoints will look at efficacy variables of ESV, EDV, EF, scar mass.
Jay Traverse, MD
Ventrix, Inc.
Open/Enrolling